%0 Journal Article
%A Miravitlles, Marc
%A Alcázar, Bernardino
%A Alvarez, Francisco Javier
%A Bazús, Teresa
%A Calle, Myriam
%A Casanova, Ciro
%A Cisneros, Carolina
%A de-Torres, Juan P
%A Entrenas, Luis M
%A Esteban, Cristóbal
%A García-Sidro, Patricia
%A Cosio, Borja G
%A Huerta, Arturo
%A Iriberri, Milagros
%A Izquierdo, José Luis
%A López-Viña, Antolín
%A López-Campos, José Luis
%A Martínez-Moragón, Eva
%A Pérez de Llano, Luis
%A Perpiñá, Miguel
%A Ros, José Antonio
%A Serrano, José
%A Soler-Cataluña, Juan José
%A Torrego, Alfons
%A Urrutia, Isabel
%A Plaza, Vicente
%T What pulmonologists think about the asthma-COPD overlap syndrome.
%D 2015
%@ 1176-9106
%U http://hdl.handle.net/10668/2348
%X BACKGROUNDSome patients with COPD may share characteristics of asthma; this is the so-called asthma-COPD overlap syndrome (ACOS). There are no universally accepted criteria for ACOS, and most treatments for asthma and COPD have not been adequately tested in this population.MATERIALS AND METHODSWe performed a survey among pulmonology specialists in asthma and COPD aimed at collecting their opinions about ACOS and their attitudes in regard to some case scenarios of ACOS patients. The participants answered a structured questionnaire and attended a face-to-face meeting with the Metaplan methodology to discuss different aspects of ACOS.RESULTSA total of 26 pulmonologists with a mean age of 49.7 years participated in the survey (13 specialists in asthma and 13 in COPD). Among these, 84.6% recognized the existence of ACOS and stated that a mean of 12.6% of their patients might have this syndrome. In addition, 80.8% agreed that the diagnostic criteria for ACOS are not yet well defined. The most frequently mentioned characteristics of ACOS were a history of asthma (88.5%), significant smoking exposure (73.1%), and postbronchodilator forced expiratory volume in 1 second/forced vital capacity <0.7 (69.2%). The most accepted diagnostic criteria were eosinophilia in sputum (80.8%), a very positive bronchodilator test (69.2%), and a history of asthma before 40 years of age (65.4%). Up to 96.2% agreed that first-line treatment for ACOS was the combination of a long-acting β2-agonist and inhaled steroid, with a long-acting antimuscarinic agent (triple therapy) for severe ACOS.CONCLUSIONMost Spanish specialists in asthma and COPD agree that ACOS exists, but the diagnostic criteria are not yet well defined. A previous history of asthma, smoking, and not fully reversible airflow limitation are considered the main characteristics of ACOS, with the most accepted first-line treatment being long-acting β2-agonist/inhaled corticosteroids.
%K Asthma
%K COPD
%K Survey
%K ACOS
%K Guidelines
%K Asma
%K Antiasmáticos
%K Broncodilatadores
%K Consenso
%K Corticoesteroides
%K Enfermedad pulmonar obstructiva crónica
%~